Paris, France

Gerard Eberl

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gerard Eberl: Innovator in Bacterial Culturing and Inflammation Research

Introduction

Gerard Eberl is a notable inventor based in Paris, France, recognized for his contributions to the fields of microbiology and inflammation research. With a total of five patents to his name, Eberl has made significant strides in developing methods that advance our understanding of bacterial cultures and their implications in health.

Latest Patents

Eberl's latest patents include a method of culturing segmented filamentous bacteria in vitro. This invention relates to an in vitro method of culturing a segmented filamentous bacterium strain, which involves co-culturing the strain with a eukaryotic host cell. The culture is performed at an oxygen level inferior to 5% in a rich tissue culture liquid medium containing bacterial medium components, including iron. Another significant patent is focused on ADAM12 inhibitors and their use against inflammation-induced fibrosis. This invention addresses the field of fibrosis and inflammation, particularly the use of ADAM12 inhibitors to prevent or treat inflammation-induced fibrosis. It also explores the use of ADAM12 as a marker for inflammation-induced fibrosis and the ablation of ADAM12 expressing cells as a therapeutic approach to interfere with the development of pro-fibrotic cells.

Career Highlights

Throughout his career, Gerard Eberl has worked with prestigious institutions, including the Institut Pasteur and Fondation Imagine. His work has been pivotal in advancing research in microbiology and therapeutic approaches to inflammation.

Collaborations

Eberl has collaborated with notable colleagues, including Lucie Peduto and Djahida Bouskra. These collaborations have contributed to the innovative research and development of his patented methods.

Conclusion

Gerard Eberl's innovative work in bacterial culturing and inflammation research has led to significant advancements in the field. His patents reflect a commitment to improving our understanding of complex biological processes and their implications for health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…